卫宁健康
(300253)
| 流通市值：126.30亿 | | | 总市值：149.91亿 |
| 流通股本：18.55亿 | | | 总股本：22.01亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,482,174,028.84 | 994,411,309.05 | 397,456,279.95 | 2,106,166,908.59 |
| 营业收入 | 1,482,174,028.84 | 994,411,309.05 | 397,456,279.95 | 2,106,166,908.59 |
| 二、营业总成本 | 1,749,247,317.63 | 1,139,874,224.5 | 464,227,086.2 | 2,323,174,988.34 |
| 营业成本 | 1,017,162,756.17 | 659,615,116.82 | 275,146,136.39 | 1,414,739,619.03 |
| 税金及附加 | 11,622,553.77 | 7,654,240.43 | 3,027,847.08 | 14,945,739.37 |
| 销售费用 | 238,662,699.24 | 153,153,622.35 | 51,356,578.05 | 319,760,538.72 |
| 管理费用 | 181,462,588.98 | 114,905,731.48 | 38,698,318.24 | 178,034,643.6 |
| 研发费用 | 257,357,855.76 | 172,075,034.56 | 80,501,214.58 | 333,543,196.22 |
| 财务费用 | 42,978,863.71 | 32,470,478.86 | 15,496,991.86 | 62,151,251.4 |
| 其中:利息费用 | 53,317,164.03 | 35,357,639.79 | 17,707,561.39 | 68,600,185.44 |
| 其中:利息收入 | 10,680,449.52 | 3,088,465.85 | 2,322,202.51 | 6,920,521.86 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -7,893,141.85 | -4,195,055.53 | -922,774.07 | -24,406,986.94 |
| 加:投资收益 | -21,104,124.41 | -14,854,327.55 | -7,136,990.91 | -26,099,660.2 |
| 资产处置收益 | 192,563.08 | 192,799.43 | 2,332.33 | 3,050,417.08 |
| 资产减值损失(新) | -79,599,777.2 | -95,347,617.54 | -3,726,883.3 | -140,857,646.94 |
| 信用减值损失(新) | -5,325,409.01 | -21,898,785.46 | 35,891,106.02 | -110,650,502.69 |
| 其他收益 | 66,943,753.49 | 52,827,402.33 | 29,312,009.63 | 97,832,804.8 |
| 四、营业利润 | -313,859,424.69 | -228,738,499.77 | -13,352,006.55 | -418,139,654.64 |
| 加:营业外收入 | 77,850.16 | 934.25 | 10,165.22 | 222,783.54 |
| 减:营业外支出 | 1,236,250.66 | 195,966.14 | 94,123.04 | 24,559,841.67 |
| 五、利润总额 | -315,017,825.19 | -228,933,531.66 | -13,435,964.37 | -442,476,712.77 |
| 减:所得税费用 | -51,119,412.86 | -35,419,051.95 | -12,096,032.52 | -58,304,238.43 |
| 六、净利润 | -263,898,412.33 | -193,514,479.71 | -1,339,931.85 | -384,172,474.34 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -263,898,412.33 | -193,514,479.71 | -1,339,931.85 | -384,172,474.34 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -240,552,200.5 | -176,397,147.97 | 14,030,859.04 | -373,882,252.65 |
| 少数股东损益 | -23,346,211.83 | -17,117,331.74 | -15,370,790.89 | -10,290,221.69 |
| 扣除非经常损益后的净利润 | -247,344,169.33 | -185,870,075.74 | 1,526,701.35 | -354,567,960.77 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.11 | -0.08 | 0.01 | -0.17 |
| (二)稀释每股收益 | -0.11 | -0.08 | 0.01 | -0.17 |
| 九、综合收益总额 | -263,898,412.33 | -193,514,479.71 | -1,339,931.85 | -384,172,474.34 |
| 归属于母公司股东的综合收益总额 | -240,552,200.5 | -176,397,147.97 | 14,030,859.04 | -373,882,252.65 |
| 归属于少数股东的综合收益总额 | -23,346,211.83 | -17,117,331.74 | -15,370,790.89 | -10,290,221.69 |
| 公告日期 | 2026-10-28 | 2026-08-26 | 2026-04-23 | 2026-04-15 |
| 审计意见(境内) | | | | 标准无保留意见 |